ProfileGDS4718 / 203387_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 57% 55% 58% 64% 78% 82% 59% 53% 60% 62% 66% 76% 86% 75% 66% 69% 83% 76% 50% 61% 64% 61% 64% 65% 84% 64% 75% 67% 81% 67% 76% 65% 59% 85% 90% 78% 65% 69% 63% 75% 82% 73% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3240163
GSM549102patient 115, normal, homogenized [OPG study]5.950357
GSM549104patient 119, normal, homogenized [OPG study]5.7939555
GSM549108patient 138, normal, homogenized [OPG study]6.0442658
GSM549119patient 077, normal, homogenized [OPG study]6.4306364
GSM549133patient 032, cancer, homogenized [OPG study]7.7361678
GSM549139patient 042, cancer, homogenized [OPG study]8.1464982
GSM549099patient 107, normal, homogenized [OPG study]6.0460859
GSM549109patient 139, normal, homogenized [OPG study]5.7311453
GSM549110patient 046, normal, homogenized [OPG study]6.1084760
GSM549114patient 063, normal, homogenized [OPG study]6.2484962
GSM549122patient 082, normal, homogenized [OPG study]6.5648666
GSM549134patient 033, cancer, homogenized [OPG study]7.4196876
GSM549136patient 036, cancer, homogenized [OPG study]8.6694886
GSM549140patient 044, cancer, homogenized [OPG study]7.3808875
GSM549111patient 047, normal, homogenized [OPG study]6.5971666
GSM549113patient 057, normal, homogenized [OPG study]6.8472669
GSM549132patient 031, cancer, homogenized [OPG study]8.1808783
GSM549137patient 038, cancer, homogenized [OPG study]7.5109676
GSM549142patient 047, cancer, homogenized [OPG study]5.6544350
GSM549100patient 110, normal, homogenized [OPG study]6.1775161
GSM549107patient 135, normal, homogenized [OPG study]6.4144564
GSM549115patient 068, normal, homogenized [OPG study]6.1739161
GSM549116patient 072, normal, homogenized [OPG study]6.4394664
GSM549120patient 078, normal, homogenized [OPG study]6.5138665
GSM549131patient 030, cancer, homogenized [OPG study]8.4354184
GSM549118patient 074, normal, homogenized [OPG study]6.3953964
GSM549129patient 027, cancer, homogenized [OPG study]7.3802275
GSM549123patient 088, normal, homogenized [OPG study]6.6241967
GSM549124patient 006, cancer, homogenized [OPG study]7.9423281
GSM549126patient 015, cancer, homogenized [OPG study]6.6385367
GSM549128patient 025, cancer, homogenized [OPG study]7.5130176
GSM549103patient 117, normal, homogenized [OPG study]6.4828565
GSM549117patient 073, normal, homogenized [OPG study]5.9845559
GSM549138patient 041, cancer, homogenized [OPG study]8.5062185
GSM549141patient 045, cancer, homogenized [OPG study]9.2053290
GSM549130patient 028, cancer, homogenized [OPG study]7.5757878
GSM549101patient 111, normal, homogenized [OPG study]6.4949765
GSM549105patient 128, normal, homogenized [OPG study]6.7967669
GSM549106patient 134, normal, homogenized [OPG study]6.3796263
GSM549112patient 048, normal, homogenized [OPG study]7.3168875
GSM549125patient 011, cancer, homogenized [OPG study]8.0849682
GSM549127patient 024, cancer, homogenized [OPG study]7.2250473
GSM549135patient 035, cancer, homogenized [OPG study]8.1494281